Glycosaminoglycans (GAGs) are acidic, highly sulfated, complex, linear, natural heteropolysaccharides distributed among all organisms and composed of a variable number of repeating disaccharide units. Each disaccharide consists of one hexosamine, Dgalactosamine (GalN) or D-glucosamine (GlcN), and one uronic acid, D-glucuronic acid (GlcA) or L-iduronic acid (IdoA) or neutral hexose, D-galactose (Gal). According to the type of the monosaccharide units and the glycosidic bonds between them, GAGs can be divided into four main categories: (1) hyaluronic acid or hyaluronan (HA); (2) chondroitin sulfate (CS) and dermatan sulfate (DS); (3) heparan sulfate (HS) and heparin (Hep); and (4) keratan sulfate (KS) (Fig. 5.1). GAGs are present in all animals and some of them like Hep, CS and DS are extracted from terrestrial and marine soft tissues and cartilages for therapeutic uses. They are synthesized as polymers of repeating disaccharides with an N-acetyl-hexosamine (GalNAc or Glc- NAc) as one of the sugars. The alternating sugar is GlcA with the exception of KS which contains galactose instead. HA, very peculiar because it is neither sulfated nor covalently linked to a protein, containing GlcNAc, is not further modified, whereas the other classes are modified by: (1) the addition of O-sulfate groups on various hydroxyls (the three classes); (2) 5-epimerization of someGlcA residues to form IdoA residues (DS, HS, Hep); and (3) removal of acetyl residues from some hexosamines

CHONDROITIN SULFATE AS A BIOACTIVE MACROMOLECULE FOR ADVANCED BIOLOGICAL APPLICATIONS AND THERAPIES / Volpi, Nicola. - (2016), pp. 79-92. [10.1002/9781119126218.ch5]

CHONDROITIN SULFATE AS A BIOACTIVE MACROMOLECULE FOR ADVANCED BIOLOGICAL APPLICATIONS AND THERAPIES

VOLPI, Nicola
2016

Abstract

Glycosaminoglycans (GAGs) are acidic, highly sulfated, complex, linear, natural heteropolysaccharides distributed among all organisms and composed of a variable number of repeating disaccharide units. Each disaccharide consists of one hexosamine, Dgalactosamine (GalN) or D-glucosamine (GlcN), and one uronic acid, D-glucuronic acid (GlcA) or L-iduronic acid (IdoA) or neutral hexose, D-galactose (Gal). According to the type of the monosaccharide units and the glycosidic bonds between them, GAGs can be divided into four main categories: (1) hyaluronic acid or hyaluronan (HA); (2) chondroitin sulfate (CS) and dermatan sulfate (DS); (3) heparan sulfate (HS) and heparin (Hep); and (4) keratan sulfate (KS) (Fig. 5.1). GAGs are present in all animals and some of them like Hep, CS and DS are extracted from terrestrial and marine soft tissues and cartilages for therapeutic uses. They are synthesized as polymers of repeating disaccharides with an N-acetyl-hexosamine (GalNAc or Glc- NAc) as one of the sugars. The alternating sugar is GlcA with the exception of KS which contains galactose instead. HA, very peculiar because it is neither sulfated nor covalently linked to a protein, containing GlcNAc, is not further modified, whereas the other classes are modified by: (1) the addition of O-sulfate groups on various hydroxyls (the three classes); (2) 5-epimerization of someGlcA residues to form IdoA residues (DS, HS, Hep); and (3) removal of acetyl residues from some hexosamines
2016
Biomaterials from nature for advanced devices and therapies
Edited by Nuno M. Neves and Rui L. Reis.
9781119178071
John Wiley & Sons
STATI UNITI D'AMERICA
CHONDROITIN SULFATE AS A BIOACTIVE MACROMOLECULE FOR ADVANCED BIOLOGICAL APPLICATIONS AND THERAPIES / Volpi, Nicola. - (2016), pp. 79-92. [10.1002/9781119126218.ch5]
Volpi, Nicola
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1132304
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact